Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Worth repeating because this is HUGE!!!!
View:
Post by subaru1i on Mar 27, 2024 2:41pm

Worth repeating because this is HUGE!!!!

Keith"we are preparing for future EPIDIOLEX generic launch for the US market...He also discussed the unique place MPL is in with potential DEA rescheduling, which he said could include strict NEW guidelines, and FDA oversight, ..,ONE of FEW GLOBALLY who've received FDA inspection/APPROVED facility for the cultivation of cannabis and derivative products and DEA import permits for cannabis products..
Comment by subaru1i on Mar 27, 2024 2:43pm
DEA rescheduling.....'strict new guidelines'........PHARMACEUTICAL APPLICATIONS...which ties in with "FDA oversight".   This is gonna bust wide open once the DEA reschedules.   I might pick up another 250,000 shares tomorrow!!!  
Comment by alleyesonme on Mar 27, 2024 3:24pm
I Agree, the broad investor base does not understand the implications of U.S rescheduling, MPL is the only North American site to have FDA approval for cannabis and cannabis derivative cultivation and manufacturing. If rescheduling occurs with FDA oversight and guidelines MPL could be the only Canadian firm able to EXPORT to the U.S market.....industry players and pharma will understand that ...more  
Comment by subaru1i on Mar 27, 2024 3:27pm
alleyesonme....believe it or not I have a 100 day GIC maturing tomorrow, appt on Thurs at 1 pm to renew...was thinking of using some of it to pick up another 250,000 shares BUT I can't because that in my eyes would be taking advantage of my relationship Athea and she is the one that brought me the greatest gift of Love π I have ever received.   
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities